These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 27490935)
21. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies. Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091 [TBL] [Abstract][Full Text] [Related]
22. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946 [TBL] [Abstract][Full Text] [Related]
23. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Josephs KA; Duffy JR Curr Opin Neurol; 2008 Dec; 21(6):688-92. PubMed ID: 18989114 [TBL] [Abstract][Full Text] [Related]
24. [Pathologic diagnosis of non-Alzheimer type dementia]. Zhu MW; Wang LN; Li XH; Hu YZ Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):408-12. PubMed ID: 15498207 [TBL] [Abstract][Full Text] [Related]
25. Tau gene mutations and their effects. Goedert M Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090 [TBL] [Abstract][Full Text] [Related]
26. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946 [TBL] [Abstract][Full Text] [Related]
27. Structural anatomy of empathy in neurodegenerative disease. Rankin KP; Gorno-Tempini ML; Allison SC; Stanley CM; Glenn S; Weiner MW; Miller BL Brain; 2006 Nov; 129(Pt 11):2945-56. PubMed ID: 17008334 [TBL] [Abstract][Full Text] [Related]
29. Natural history and clinical features of progressive supranuclear palsy: a clinical study. Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074 [TBL] [Abstract][Full Text] [Related]
30. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders. Buée-Scherrer V; Buée L; Leveugle B; Perl DP; Vermersch P; Hof PR; Delacourte A Ann Neurol; 1997 Sep; 42(3):356-9. PubMed ID: 9307257 [TBL] [Abstract][Full Text] [Related]
31. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. de Bruin VM; Lees AJ; Daniel SE Mov Disord; 1992 Oct; 7(4):355-8. PubMed ID: 1484531 [TBL] [Abstract][Full Text] [Related]
32. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
33. [Cytoskeletal changes in Alzheimer's disease and other neurodegenerative disorders]. Astarloa R; Alvarez-Cermeño JC Neurologia; 1990 Feb; 5(2):52-61. PubMed ID: 2141790 [No Abstract] [Full Text] [Related]
34. Primary progressive freezing gait: a syndrome with many causes. Factor SA; Higgins DS; Qian J Neurology; 2006 Feb; 66(3):411-4. PubMed ID: 16476942 [TBL] [Abstract][Full Text] [Related]